Carfilzomib injection is a medication used to treat multiple myeloma, a type of blood cancer that affects plasma cells. It belongs to a class of drugs called proteasome inhibitors, which work by blocking the action of proteasomes, which are enzymes that break down proteins in cells.
The medication is given as an injection into a vein (intravenously) by a healthcare professional. The injection may be given once or twice a week, depending on the dosing schedule prescribed by the healthcare provider.
Carfilzomib injection may cause some side effects, including nausea, vomiting, diarrhea, fatigue, fever, and decreased appetite. It may also cause more serious side effects, such as low blood cell counts or heart problems. If you experience any severe or persistent side effects, be sure to contact your doctor or healthcare provider.
As with any cancer medication, carfilzomib injection may not be suitable for everyone. It is important to discuss any medical conditions, allergies, or other medications you may be taking with your healthcare provider before starting treatment. It is also important to inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding, as the medication may harm an unborn or nursing baby.